CHRA yields 33.56% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 5
Combined, CHRA + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHRA + MRK for your $10,000?
Charah Solutions, Inc. provides environmental services to the power generation industry in the United States. The company offers remediation and compliance services, including environmental management of landfills for coal-fired power generation facilities and new and existing ash ponds; and active pond management services, such as closure by removal, cap-in-place, and design and construction of new ponds. Its remediation and compliance services also include landfill development, construction, and management; site evaluation and characterization; preliminary design and cost estimates with life-cycle analysis; hydrogeological assessment; groundwater and containment modeling; permit application and processing for expansions and greenfield sites; design engineering; construction of landfills and cap and cover systems; conversion of impoundments to landfill sites; quality assurance and control, and documentation; engineered fills (off-site); and other related services. In addition, the company recycles recurring and contracted volumes of coal-fired power generation waste byproducts comprising bottom ash, fly ash, and gypsum byproducts for the use in various industrial purposes. Further, it provides coal ash management services; fossil services that include silo management, on-site ash transportation, and capture and disposal of ash byproduct from coal power operations; and manages combustion byproducts comprising bottom ash, as well as disposal of flue gas desulfurization gypsum, Pozatec/fixated scrubber sludge, and fluidized bed combustion fly ash; and environmental risk transfer services that manages the sites' remediation requirements. Charah Solutions, Inc. was founded in 1987 and is headquartered in Louisville, Kentucky.
Full CHRA Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.